COMMUNIQUÉS West-GlobeNewswire
-
IBA – ACQUISITION D’ACTIONS PROPRES
15/06/2026 -
KFSH Demonstrates How Specialized Hospitals Can Drive Health System Innovation at HLTH Europe 2026
15/06/2026 -
Le KFSH montre comment les hôpitaux spécialisés peuvent stimuler l’innovation au sein des systèmes de santé lors du congrès HLTH Europe 2026
15/06/2026 -
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
15/06/2026 -
France Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 in San Diego
15/06/2026 -
Medicana Health Group Celebrates Two Major Recognitions in Capital Magazine’s CSR Research
15/06/2026 -
Applied Biologics Reports Statistically Significant Improvement in Wound Closure Outcomes in Updated Analyses of the CAMPX Randomized Controlled Trial Evaluating XWRAP®
15/06/2026 -
Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment
15/06/2026 -
Wildfire Smoke Reaches Record Levels as Americans Struggle to Breathe
15/06/2026 -
BioSyent to Present at Planet MicroCap Las Vegas
15/06/2026 -
SafeSpace Global Appoints Michael Hrynuik as Chief Financial Officer
15/06/2026 -
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
15/06/2026 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
15/06/2026 -
AI is changing what is possible in the $10 trillion food industry. Anterra Capital is backing what comes next.
15/06/2026 -
ProSomnus® Sleep Technologies and MonitAir® Announce Collaboration to Enhance Connected Care for Obstructive Sleep Apnea
15/06/2026 -
XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis
15/06/2026 -
XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active
15/06/2026 -
BVI Expands Commitment to Ophthalmic Education with New Experience Hub in Europe
15/06/2026 -
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product
15/06/2026
Pages